MIR31HG and non-small cell lung carcinoma: To explore the role of LOC554202 in acquired resistance to gefitinib, we first established in vitro gefitinib-resistant PC9GR and HCC827GR cell models by culturing gefitinib-sensitive NSCLC cells lines (PC9 and HCC827) with escalating doses of gefitinib.